Publication - Advice and guidance

Coronavirus (COVID-19): AstraZeneca (ChAdOx1-S [Recombinant]) vaccine - national protocol - edition 2.2

Published: 4 Jun 2021

This protocol is for the supply and administration of AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) to individuals in accordance with the national COVID-19 vaccination programme.

37 page PDF

550.4 kB

37 page PDF

550.4 kB

Contents
Coronavirus (COVID-19): AstraZeneca (ChAdOx1-S [Recombinant]) vaccine - national protocol - edition 2.2
Annex B: Practitioner authorisation sheet

37 page PDF

550.4 kB

Annex B: Practitioner authorisation sheet

AstraZeneca COVID-19 Vaccine (ChAdOx1-S [Recombinant]) Vaccine Protocol

Valid from:
Expiry:

Before signing this Protocol, check that the document has had the necessary authorisations. Without these, this Protocol is not lawfully valid.

Practitioner

By signing this Protocol you are indicating that you agree to its contents and that you will work within it.

Protocols do not remove inherent professional obligations or accountability.

It is the responsibility of each practitioner to practise only within the bounds of their own competence and any appropriate professional code of conduct.

Alternate text for the figure

Person authorising on behalf of the Provider

Alternate text for the figure

Note to person authorising on behalf of Provider

Score through unused rows in the list of practitioners to prevent practitioner additions post managerial authorisation.

This authorisation sheet should be retained to serve as a record of those practitioners authorised to work under this Protocol.


Contact

Email: VaccinationsDelivery@gov.scot